Saturday December 14, 2019

‘We don’t pay patients for what we do’

Anne Jones of Genomics Medicine Ireland wants your DNA, and insists it will be ‘rigorously’ protected

17th March, 2019
Anne Jones, chief executive at GMI Picture: Bryan Meade

Medical research company Genomics Medicine Ireland (GMI) will go for an initial public offering within the next two years.

Based in Dublin, GMI was acquired by Chinese genomics specialists WuXi Nextcode last November. The value of the deal was not disclosed, but the company committed to investing $400 million to GMI’s plan to sequence the genomes of 400,000 people in Ireland.

It costs about $2,500 for each genome sequenced, so GMI’s plan to map the...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Patient advocates are unhappy with the latest report on the national cervical screening programme and want further reviews, but some medical experts say resources would be better used elsewhere

Susan Mitchell | 6 days ago

Britain’s so-called ‘election of a generation’ is as muddled and confused as the Brexit debate that preceded it. On the ground in a number of constituencies, it proves difficult to take the temperature of this strangest of political contests

Susan O'Keeffe | 6 days ago

Undisclosed pay deals, secret pensions and underpayment of tax are just some of the problems left by John Delaney, as last week’s press conference revealed that the FAI has a long road ahead of it

Róisín Burke | 6 days ago